- Previous Close
180.20 - Open
191.95 - Bid 180.10 x --
- Ask 183.75 x --
- Day's Range
176.55 - 191.95 - 52 Week Range
118.95 - 216.00 - Volume
603 - Avg. Volume
3,560 - Market Cap (intraday)
1.183B - Beta (5Y Monthly) 1.02
- PE Ratio (TTM)
45.48 - EPS (TTM)
4.04 - Earnings Date May 22, 2025 - May 26, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Sep 12, 2019
- 1y Target Est
--
Source Natural Foods and Herbal Supplements Limited manufactures and sells ayurveda, health and dietary supplements, and food products in India. It offers beverages, supplements, arkas, single herbs, and churnas products. The company provides healthcare products for ortho, diabetic, digestive, respiratory, skin, heart, liver, kidney care, pain relief, weight loss, mental wellness, immune-modulator and anti-oxidants, natural vitamins and supplements, opthal and ENT care, women's wellness, and hair and scalp health. In addition, it offers food products, including health drinks, herbal teas, chayawanprash, health powders, masalas and spices, staples and grains, and flours. The company was formerly known as Inwinex Pharmaceuticals Limited and changed its name to Source Natural Foods and Herbal Supplements Limited in June 2012. The company was incorporated in 1995 and is based in Bengaluru, India. Source Natural Foods and Herbal Supplements Limited is a subsidiary of Sriveda Sattva Private Limited.
www.source-natural.comRecent News: SOURCENTRL.BO
View MorePerformance Overview: SOURCENTRL.BO
Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SOURCENTRL.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SOURCENTRL.BO
View MoreValuation Measures
Market Cap
1.16B
Enterprise Value
1.15B
Trailing P/E
44.60
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.25
Price/Book (mrq)
5.60
Enterprise Value/Revenue
3.22
Enterprise Value/EBITDA
21.37
Financial Highlights
Profitability and Income Statement
Profit Margin
7.28%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
356.86M
Net Income Avi to Common (ttm)
25.99M
Diluted EPS (ttm)
4.04
Balance Sheet and Cash Flow
Total Cash (mrq)
75.18M
Total Debt/Equity (mrq)
30.41%
Levered Free Cash Flow (ttm)
--